COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma

Author:

Wu Anbang1ORCID,Yang Hongmin1,Xiao Tengfei1,Gu Wangning1,Li He1,Chen Pan1

Affiliation:

1. Hunan Cancer Hospital

Abstract

Abstract Background Ferroptosis, a type of autophagy-dependent cell death, is intricately related to the pathogenesis of lung adenocarcinoma (LUAD). The research focus of this study was to investigate the involvement of coatomer protein complex I subunit zeta 1 (COPZ1) in ferroptosis and ferritinophagy in LUAD. Methods In this study, clinical samples of LUAD and para-carcinoma tissues were gathered. Lentiviral vectors were utilized to establish COPZ1-deficient LUAD cell model and xenograft model. These models were analyzed to assess tumor growth, lipid peroxidation levels, autophagy activation, and iron metabolism. To demonstrate the regulatory effects of COPZ1 on its downstream targets, qRT-PCR, Western blot, and co-immunoprecipitation (co-IP) assay were conducted. Moreover, NCOA4 knockdown plasmid was applied. The location of ferritin and lysosomes were examined using immunofluorescence staining. Results The study revealed that LUAD tissues and cells exhibited elevated expression of COPZ1. COPZ1 silencing inhibited xenograft tumor growth and induced apoptosis. COPZ1 silencing also promoted the accumulation of ROS, Fe2+, MDA and 4-HNE while reducing GSH-Px levels. In addition, COPZ1 was found to directly bind to nuclear receptor coactivator 4 (NCOA4). COPZ1 silencing inhibit the expression of FTH1 and promoted the expression of NCOA4 and LC3. NCOA4 knockdown reversed the iron metabolism and lipid peroxidation regulation induced by COPZ1 silencing. Furthermore, COPZ1 silencing induced the translocation of ferritin to lysosomes for degradation, while NCOA4 knockdown disrupted this process. Conclusion This study presents novel findings showing that COPZ1 regulates NCOA4-mediated ferritinophagy and ferroptosis. These results offer new insights into the development and potential treatment of LUAD.

Publisher

Research Square Platform LLC

Reference38 articles.

1. Cancer Progress and Priorities: Lung Cancer;Schabath MB;Cancer Epidemiol Biomarkers Prev,2019

2. Non-small cell lung cancer in China;Chen P;Cancer Commun (Lond),2022

3. Pathology of lung cancer;Travis WD;Clin Chest Med,2011

4. Update 2020: Management of Non-Small Cell Lung Cancer;Alexander M;Lung,2020

5. Xiong R et al. Ferroptosis: A New Promising Target for Lung Cancer Therapy. Oxid Med Cell Longev, 2021. 2021: p. 8457521.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3